Cultured epidermal autografts developed successfully in Korea

Published: 2002-12-18 06:56:00

Updated: 2002-12-18 06:56:00

The Food and Drug Administration (KFDA) said it has approved market authorization of Tego Science's biotechnology-based Holoderm, cultured epidermal autograft, a skin replacement product that can permanently close a burn wound.

Tego Science said that Holoderm was successfully developed for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK